# A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: AbbVie · Condition: Epithelial Ovarian Cancer

- Company: AbbVie
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06890338

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.